EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Mitotic deacetylase complex (MiDAC) recognizes the HIV-1 core promoter to control activated viral gene expression

Emmanuelle Wilhelm, Mikaël Poirier, Morgane Da Rocha, Mikaël Bédard, Patrick P McDonald, Pierre Lavigne, Christie L Hunter, Brendan Bell iD

PLOS Pathogens · 2024

DOI: 10.1371/journal.ppat.1011821 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS Pathogens, 2024. Verfasst von Emmanuelle Wilhelm und 7 weiteren Autor:innen. Beteiligte Einrichtung: OSE Immunotherapeutics, Nantes, France. Hauptthemen laut MEDLINE: HIV-1, Gene Expression Regulation, Viral, Promoter Regions, Genetic, Virus Latency. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 119 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: CIHR Operating Grant, The Canadian HIV Cure Enterprise Team, CIHR.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The human immunodeficiency virus (HIV) integrates into the host genome forming latent cellular reservoirs that are an obstacle for cure or remission strategies. Viral transcription is the first step in the control of latency and depends upon the hijacking of the host cell RNA polymerase II (Pol II) machinery by the 5’ HIV LTR. Consequently, “block and lock” or “shock and kill” strategies for an HIV cure depend upon a full understanding of HIV transcriptional control. The HIV trans-activating protein, Tat, controls HIV latency as part of a positive feed-forward loop that strongly activates HIV transcription. The recognition of the T ATA box and a djacent s equences of H IV e ssential for T at trans -activation (TASHET) of the core promoter by host cell p re- i nitiation c omplexes of H IV (PICH) has been shown to be necessary for Tat trans -activation, yet the protein composition of PICH has remained obscure. Here, DNA-affinity chromatography was employed to identify the mitotic deacetylase complex (MiDAC) as selectively recognizing TASHET. Using biophysical techniques, we show that the MiDAC subunit DNTTIP1 binds directly to TASHET, in part via its CTGC DNA motifs. Using co-immunoprecipitation assays, we show that DNTTIP1 interacts with MiDAC subunits MIDEAS and HDAC1/2. The Tat-interacting protein, NAT10, is also present in HIV-bound MiDAC. Gene silencing revealed a functional role for DNTTIP1, MIDEAS, and NAT10 in HIV expression in cellulo . Furthermore, point mutations in TASHET that prevent DNTTIP1 binding block the reactivation of HIV by latency reversing agents (LRA) that act via the P-TEFb/7SK axis. Our data reveal a key role for MiDAC subunits DNTTIP1, MIDEAS, as well as NAT10, in Tat-activated HIV transcription and latency. DNTTIP1, MIDEAS and NAT10 emerge as cell cycle-regulated host cell transcription factors that can control activated HIV gene expression, and as new drug targets for HIV cure strategies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HIV-1Gene Expression Regulation, ViralPromoter Regions, GeneticVirus LatencyHIV InfectionsHumanstat Gene Products, Human Immunodeficiency VirusViral Transcription

Substanzen

tat Gene Products, Human Immunodeficiency Virus

Autor:innen und Institutionen

  • OSE Immunotherapeutics, Nantes, France.
  • Charles River Laboratories, Sherbrooke, Québec, Canada.
  • Département de microbiologie et d'infectiologie, Faculté de médecine et sciences de la santé, Université de Sherbrooke, and Centre de recherche du CHUS, Sherbrooke, Québec, Canada.
  • Département de Biochimie et de Génomique Fonctionnelle, Faculté de médecine et sciences de la santé, Université de Sherbrooke, and Centre de recherche du CHUS, Sherbrooke, Québec, Canada.
  • Pulmonary Division, Medicine Faculty, Université de Sherbrooke; and Centre de recherche du CHUS, Sherbrooke, Québec, Canada.
  • SCIEX, Redwood City, California, United States of America.

ORCID-Profile: Brendan Bell

Förderung

  • CIHR Operating Grant
  • The Canadian HIV Cure Enterprise Team
  • CIHR
  • FQRNT
  • CFUW
  • NSERC
  • Anonymus donor

Zitieren

APA

Wilhelm, E., Poirier, M., Da Rocha, M., Bédard, M., McDonald, P. P., Lavigne, P., Hunter, C. L., & Bell, B. (2024). Mitotic deacetylase complex (MiDAC) recognizes the HIV-1 core promoter to control activated viral gene expression. PLOS Pathogens. https://doi.org/10.1371/journal.ppat.1011821

Vancouver

Wilhelm E, Poirier M, Da Rocha M, Bédard M, McDonald PP, Lavigne P, et al. Mitotic deacetylase complex (MiDAC) recognizes the HIV-1 core promoter to control activated viral gene expression. PLOS Pathogens. 2024. doi:10.1371/journal.ppat.1011821

BibTeX
@article{Wilhelm2024,
  author = {Wilhelm, Emmanuelle and Poirier, Mikaël and Da Rocha, Morgane and Bédard, Mikaël and McDonald, Patrick P and Lavigne, Pierre and Hunter, Christie L and Bell, Brendan},
  title = {Mitotic deacetylase complex (MiDAC) recognizes the HIV-1 core promoter to control activated viral gene expression},
  journal = {PLOS Pathogens},
  year = {2024},
  doi = {10.1371/journal.ppat.1011821}
}
Kostenlos starten →